Fundz

Fundz Deep Dive

Everything you need to win Martin Chamberlin — in one platform.

Who to reach, what to say, and why now on Martin Chamberlin — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Martin Chamberlin — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Oppenheimer Europe Appoints Martin Chamberlin As Managing Director and Head of European Healthcare

PUBLIC · OPYJun 04, 2024•about 2 years ago

Position

Head of European Healthcare

Company

Oppenheimer &

Martin Chamberlin
New YorkFinancial ServicesFinanceFintechLendingBanking

Description

Oppenheimer Europe, a subsidiary of Oppenheimer Holdings, has announced the addition of Martin Chamberlin as Managing Director and Head of European Healthcare based in London. Chamberlin will lead the firm's newly established European healthcare practice and report to Max Lami, Chief Executive Officer of Oppenheimer Europe.

Company Information

Company

Oppenheimer &

Location

85 Broad Street

New York, United States

About

Oppenheimer & Co. Inc. is a global full-service brokerage and investment bank with over 140 years of history, originating from Fahnestock & Co. in 1881. Headquartered in New York City, the firm employs more than 3,100 people across 92 offices worldwide and manages approximately $129.8 billion in assets. The company offers a wide range of financial services tailored to individuals, families, corporate executives, foundations, and institutional investors. Its core services include wealth management, investment banking, asset management, equity research, retirement services, structured products, and risk management. Oppenheimer emphasizes personalized financial planning and innovative strategies to meet the diverse needs of its clients. Led by CEO Albert Lowenthal, the firm continues to build on its entrepreneurial spirit and commitment to delivering customized financial solutions.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Oppenheimer &'s next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.